Cytokinetics Inc (CYTK)
Activity ratios
Short-term
Turnover ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inventory turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Working capital turnover | 0.02 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.02 | 0.16 | 0.13 | 0.18 | 0.28 | 0.12 | 0.15 | 0.05 | 0.19 | 0.15 | 0.13 | 0.14 | 0.10 | 0.11 |
Cytokinetics Inc's activity ratios illustrate how the company efficiently manages its assets and liabilities to generate sales.
1. Inventory Turnover: The company's inventory turnover ratio is not provided, indicating that the frequency with which the company sells and replenishes its inventory is not available for analysis.
2. Receivables Turnover: Similar to inventory turnover, the receivables turnover ratio is not provided, making it difficult to assess how quickly Cytokinetics collects payments from customers.
3. Payables Turnover: The payables turnover ratio is also not available, preventing insights into how efficiently the company pays its suppliers.
4. Working Capital Turnover: This ratio portrays how effectively the company utilizes its working capital to generate sales. Cytokinetics showed fluctuations in its working capital turnover over the reporting periods, reflecting changes in the efficiency of utilizing its working capital to drive revenue. The ratio increased from 0.11 in March 2020 to 0.28 in June 2022, indicating an improvement in working capital efficiency. However, the ratio dropped significantly to 0.00 by June 2024, suggesting a decline in the company's ability to utilize working capital to generate sales. Overall, the trend in the working capital turnover ratio indicates varying levels of efficiency in utilizing resources to drive revenue during the reporting periods.
Average number of days
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Days of sales outstanding (DSO) | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Number of days of payables | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
The activity ratios provided for Cytokinetics Inc, including Days of Inventory on Hand (DOH), Days of Sales Outstanding (DSO), and Number of Days of Payables, are all reported as "— days" for each period from March 31, 2020, to December 31, 2024. This indicates that there is no available data or the data is not disclosed for these specific activity ratios over the respective periods.
Without the actual values for these activity ratios, it is challenging to assess the efficiency of Cytokinetics Inc's inventory management, accounts receivable collection, and accounts payable payment practices. These ratios are essential for understanding how quickly the company is turning its inventory into sales, collecting outstanding receivables from customers, and paying its suppliers.
It is recommended that stakeholders and investors closely monitor these activity ratios in future financial disclosures from Cytokinetics Inc to gain insights into the company's operational efficiency and financial management practices.
See also:
Cytokinetics Inc Short-term (Operating) Activity Ratios (Quarterly Data)
Long-term
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fixed asset turnover | — | — | — | — | — | — | 0.06 | 1.24 | 1.18 | 1.85 | 1.92 | 0.86 | 0.96 | 0.40 | 0.48 | 2.52 | 4.18 | 7.08 | 3.33 | 4.31 |
| Total asset turnover | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.11 | 0.09 | 0.14 | 0.20 | 0.08 | 0.08 | 0.03 | 0.10 | 0.10 | 0.10 | 0.11 | 0.08 | 0.09 |
The Fixed Asset Turnover ratio measures how efficiently a company utilizes its fixed assets to generate revenue. For Cytokinetics Inc, the trend in Fixed Asset Turnover has been declining over the past few years. In March 2020, the ratio was 4.31, indicating that the company generated $4.31 in revenue for every dollar of fixed assets. However, by June 2023, the ratio had dropped significantly to 0.06, suggesting a less efficient use of fixed assets to generate revenue.
On the other hand, the Total Asset Turnover ratio reflects the company's ability to generate revenue from its total assets. Cytokinetics Inc's Total Asset Turnover has also shown a downward trend over the years. The ratio was 0.09 in March 2020 and declined to 0.00 by March 2024, indicating a decrease in the company's ability to generate revenue from its total assets.
Overall, the declining trend in both the Fixed Asset Turnover and Total Asset Turnover ratios suggests that Cytokinetics Inc may be facing challenges in efficiently utilizing its assets to generate revenue. It is important for the company to address this trend to improve its long-term activity ratios and overall financial performance.
See also:
Cytokinetics Inc Long-term (Investment) Activity Ratios (Quarterly Data)